Matches 1 - 50 out of 153 1 2 3 4 >
Match Document Document Title
7612010 Use of metal complex compounds as oxidation catalysts  
Use of metal complex compounds of formula (1) and/or (1′) [L n Me m X p ] z Y q (1),
7595400 Process for the preparation of hexacyclic compounds  
This invention relates to novel processes for the preparation of compounds of the formula [1], wherein R1, R2, R3 and R4 are as defined in the claims and description as well as pharmaceutically...
7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds  
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods...
7585856 Resolvins: Biotemplates for novel therapeutic interventions  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
7537912 Methods of measuring luminogenic activity with a protected coelenterazine  
A method of measuring the enzymatic activity of a luciferase includes contacting a luminogenic protein, such as a luciferase, with a protected luminophore to form a composition; and detecting light...
7511125 Pyrimidine derivatives for labeled binding partners  
Compounds having structure (1) wherein R 1 is —H a protecting group, a linker or a binding partner; and R 2 and R 34 are as defined in the specification. The invention also provides...
7501427 Quinazoline analogs as receptor tyrosine kinase inhibitors  
This invention concerns quinazoline analogs of Formula I: where an A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is...
7456281 Nucleic acid melting analysis with saturation dyes  
Methods are provided for nucleic acid analysis wherein a target nucleic acid is mixed with a dsDNA binding dye to form a mixture. Optionally, an unlabeled probe is included in the mixture. A...
7427693 Polar liquid crystal  
Compounds that are useful in compositions for flat panel displays, for example, are provided. The compounds provided are polar, and are useful in low threshold voltage mixtures. The compounds...
7420056 Substituted bicyclic imidazo-3-ylamine compounds  
Substituted bicyclic imidazo-3-yl-amine compounds are provided, as well as processes for the production thereof and pharmaceutical formulations containing these compounds. The use of these...
7393367 Agent for dyeing keratin-based fibers  
An agent for dyeing keratin-containing fibers, especially human hair, is comprised of a cosmetic carrier, and (A) at least one compound of Formula I, wherein each of R 1 , R 2 ...
7390814 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments  
Substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments The invention relates to substituted...
7321033 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof  
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention...
7307168 Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one  
The invention relates to a process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl }-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-on e of the Formula...
7268229 Compounds to co-localize luminophores with luminescent proteins  
A method of measuring the enzymatic activity of a luciferase includes contacting a luminogenic protein, such as a luciferase, with a protected luminophore to form a composition; and detecting light...
7238771 Dibenzodiazocine polymers  
Dibenzodiazocine polymers, methods for producing dibenzodiazocine polymers, products formed from dibenzodiazocine polymers, and uses for such dibenzodiazocine polymers are provided.
7217717 Phenalene derivatives  
Novel 1,3,4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives are disclosed. These compounds inhibit epidermal growth factor receptor (“EGFR”) tyrosine kinase. These compounds and...
7176310 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents  
This invention is directed to compound of the following formula (I): wherein R 1 , R 2 , R 3 and R 4 are as described herein. These compounds and pharmaceutical compositions containing the...
7160890 Compounds specific to adenosine A3 receptor and uses thereof  
This invention pertains to compounds which specifically inhibit the adenosine A 3 receptor and the use of these compounds to treat a disease associated with A 3 adenosine receptor in a subject,...
7138363 Use of metal complex compounds as oxidation catalysts  
Use of metal complex compounds of formula (1) and/or (1′) [LnMemXp]zYq (1), [L′MemXp]zYq (1′), wherein all substituents are as defined in the claims, as catalysts for oxidation reactions, and...
7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use  
Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and...
7109195 Hexacyclic compounds and their therapeutic use  
The present invention relates to hexacyclic compound of the formula [1], wherein Z, R 3 and R 4 are as identified therein, and pharmaceutically acceptable salts thereof. These compounds are...
7094783 Bicyclic pyrimidinones as coagulation cascade inhibitors  
The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel amino-bicyclic pyrimidinone compounds of Formula (I): or a stereoisomer...
7045624 Compounds and their uses  
Use of a compound according to Formula [I]: or a salt thereof to produce a cooling sensation, wherein R 1 and R 2 are independently selected from hydrogen or halogen atoms; hydroxy, cyano,...
6962991 Process for the synthesis of pyrazolopyrimidines  
The present invention provides a nucleoside comprising a pyrazolopyrimidine base and a process for producing the same. In particular, the processes of the present invention comprises using a...
6846335 Crystal form of a perinone dye  
A novel crystal form of C.I. Solvent Orange 60 gives a higher space-time yield in dye synthesis and is more easily finished.
6833455 Bridged perinones/quinophthalones  
Disclosed herein are bridged perinones/quinophthalones of the general formula (I) or tautomeric forms thereof where X1, X2, Ar 1 Ar 2 and B are as described herein and are particularly...
6831074 Pharmaceutically active compounds  
The present invention provides a compound of formula (I): where Q is a group of formula: These compounds inhibit cyclic guanosine 3′,5′-monophosphate phosphodiesterases (cGMP PDEs). More...
6825194 Hexacyclic compounds  
The present invention relates to hexacyclic compound of the formula [1], wherein Z, R 3 and R 4 are as identified therein, and pharmaceutically acceptable salts thereof. These compounds are...
6703504 Conformationally constrained compounds as dendrimer cores  
There are provided novel chemical compounds and their uses in the preparation of polymers and oligomers, and the preparation of such compounds. In certain embodiments there are provided dendritic...
6692562 Process for making perylene pigment compositions  
This invention relates to a process of preparing a perylene pigment compositions containing a reactive co-precipitated blend of (1) about 75 to about 99.9 mol %, relative to the pigment...
6683028 Cyclic guanidine derivatives and their use as pesticides  
The invention relates to novel guanidine derivatives of the formula (I) in which A, R 1 , R 2 , R 3 and Z are as defined in the description, to a process for their preparation and to their use...
6562968 Method of purifying tetrodotoxin  
The present invention relates to a new process of purifying tetrodotoxin using high performance liquid chromatograph technology.
6491847 Discotic liquid crystal and organic electroluminescence device using same  
A novel class of discotic liquid crystals represented by the following formula was synthesized, and a layer thereof was incorporated in an organic electroluminescence device.
6491749 Core-extended perylene bisimides  
The present inventions relates to nucleus-extended perylenebisimides of formula (I) intermediates in the preparation of compounds (I) and processes for the preparation of those intermediates and...
6380193 Fused tricyclic compounds, methods and compositions for inhibiting PARP activity  
A compound of formula I: or a pharmaceutically acceptable salt, hydrate, ester, solvate, prodrug, metabolite, stereoisomer, or mixtures thereof.
6281355 Nitrogen-containing tetracyclic compounds  
A nitrogen-containing tetracyclic compound represented by the formula: ##STR1## wherein Y 1 --Y 2 --Y 3 is N--CN or a group represented by the formula: CC--NR 3 (wherein R 3 is a...
6207671 Cycloalkano-pyridines  
The cycloalkano-pyridines are prepared by reacting corresponding cycloalkano-pyridine-aldehydes with suitable organometallic compounds or Wittig or Grignard reagents or reacting compounds of the...
6143748 Process for synthesis of nucleoside analogues  
The present invention is concerned with a process for the preparation of antiviral 1,3-oxathiolane nucleosides comprising an intramolecular glycosylation reaction to produce exclusively the...
6140270 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from 2-(N,N-disubstituted) amino-4-(perfluoroalkyl)-1,3-oxazin-6-one compounds  
An improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula I ##STR1## from 2-(N,N-disubstituted)amino-4-(perfluoroalkyl)-1,3-oxazin-6-o ne compounds...
6107304 Thieno[2,3-b]pyrazolo[3,4-d]pyridine-3-ones to enhance erythropoiesis  
Invented are substituted thieno (2,3-b)pyrazolo(3,4-d)pyridin-3-ones, pharmaceutical compositions containing these compounds, and methods of using these compounds to enhance erythropoiesis. Also...
6093821 Process for preparing steroid receptor modulator compounds  
Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds,...
5958923 Use of thiazole and thiadiazole compounds  
The present invention relates to the use of thiazole and thiadiazole compounds of the following formula: ##STR1## where R 1 , A, B and Ar have the meanings stated in the description. The compounds...
5952335 Fused polycyclic heterocycle derivatives  
Novel fused polycyclic heterocycle derivatives having excellent antitumor effects and a process for producing the same. A compound represented by the following general formula (I) or...
5948903 Synthesis of 3-deazapurines  
This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of "antisense" agents, agents...
5861398 Benzoperimidine-carboxylic acids and derivatives thereof  
Benzo(e)perimidine-4-carboxamide derivatives of general structural formula I ##STR1## (where R a , R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined in the specification) have activity for...
5830931 Process for the preparation of polycyclic compounds  
Process for the preparation of compounds of the general formula (I) ##STR1## by reaction of aromatic dicarboxylic acids of the formula (II) ##STR2## or anhydrides and/or esters thereof with...
5808060 Fused isoindolones  
Disclosed are biologically active, non-indole-containing compounds referred to as fused isoindolones, which are represented by the following general formula: ##STR1## The fused indolones can be...
5779934 Fluorine-containing optically active compound, process for preparing the same and liquid crystal mixture and liquid crystal element comprising the same  
A fluorine-containing optically active compound represented by the formula (1): ##STR1## wherein R 1 is a saturated or unsaturated C 3 -C 20 alkyl group or a saturated or unsaturated C 3 -C 20 ...
5753663 Pyrimidine derivatives  
The disclosed pyrimidine derivatives, and pharmaceutically acceptable salts thereof, exhibit useful pharmacological properties, in particular use as 5HT 2C - antagonists. The invention is also...
Matches 1 - 50 out of 153 1 2 3 4 >